Secondary endpoints, such as sural nerve conduction velocity and the Karnofsky physical score showed also a significant improvement in patients treated with ALC, compared to the placebo group
We know successful weight loss requires more than medication prescriptions, Robertson explains
These findings support a role for GpoA, along with AhpD and TpxD, in enabling S
True copper or peptide allergy is uncommon but real
In animals on the AGEpromoting diet, either treatment effectively restored progressive motility (Fig
The addition of a candidate targeting glucagon, as well as GLP-1 and GIP, will add important optionality to our clinical pipeline, as we look to develop a broad portfolio of differentiated treatment options that cater to the diverse needs of people living with these highly prevalent diseases, said Martin Holst Lange, executive vice president for Development at Novo Nordisk